Press Releases
Quaker Chemical Announces First Quarter 2019 Results
The Company's first quarter of 2019 net income was
Mr. Barry continued, "With respect to the Houghton combination, we are continuing to make progress and expect to close the combination in the next couple of months. Overall, I continue to be confident in our future given our continued ability to achieve market share gains that will help offset the underlying challenges in our markets, and I remain excited for the future benefits we will achieve through our upcoming combination with Houghton."
First Quarter of 2019 Summary
Net sales were
Gross profit in the first quarter of 2019 increased
SG&A increased
During the first quarter of 2019, the Company incurred
Operating income in the first quarter of 2019 was
Other expense, net, was
Interest expense decreased
The Company's effective tax rates for the first quarters of 2019 and 2018 were 26.8% and 29.8%, respectively. These effective tax rates include the impacts of Houghton combination-related expenses, certain of which were non-deductible. Excluding the impact of Houghton combination-related expenses and all other non-core items in each quarter, the Company estimates that its first quarters of 2019 and 2018 effective tax rates would have been approximately 24% and 26%, respectively. The Company's lower first quarter of 2019 effective tax rate was largely driven by a positive impact from changes in uncertain tax positions and a shift in earnings to entities with lower effective tax rates quarter-over-quarter, which more than offset higher current quarter tax expense related to the Company recording earnings in one of its subsidiaries at a statutory tax rate of 25% during the first quarter of 2019 while it awaits recertification of a concessionary 15% tax rate. The concessionary 15% tax rate was available to the Company's subsidiary in all periods of 2018.
Equity in net income (loss) of associated companies increased
The Company's net income attributable to noncontrolling interest was consistent at
Foreign exchange negatively impacted the Company's first quarter of 2019 earnings by approximately 4% or
Balance Sheet and Cash Flow Items
The Company had net operating cash flow of less than
The Company adopted new guidance regarding the accounting and disclosure for leases in the first quarter of 2019, as required. Adoption of this lease accounting guidance did not have a material impact on the Company's reported earnings or cash flows, however, adoption did result in a material impact to the Company's balance sheet to establish right of use lease assets and associated lease liabilities. As of
Houghton Combination
In
Non-GAAP Measures
The information included in this public release includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, non-GAAP operating income, non-GAAP net income and non-GAAP earnings per diluted share. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not indicative of future operating performance or not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.
The Company presents EBITDA which is calculated as net income attributable to the Company before depreciation and amortization, interest expense, net, and taxes on income before equity in net income (loss) of associated companies. The Company also presents adjusted EBITDA which is calculated as EBITDA plus or minus certain items that are not indicative of future operating performance or not considered core to the Company's operations. In addition, the Company presents non-GAAP operating income which is calculated as operating income plus or minus certain items that are not indicative of future operating performance or not considered core to the Company's operations. Adjusted EBITDA margin and non-GAAP operating margin are calculated as the percentage of adjusted EBITDA and non-GAAP operating income to consolidated net sales, respectively. The Company believes these non-GAAP measures provide transparent and useful information and are widely used by analysts, investors, and competitors in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures. Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, net - adjusted, and taxes on income before equity in net income (loss) of associated companies - adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA. Non-GAAP earnings per diluted share is calculated as non-GAAP net income per diluted share as accounted for under the "two-class share method." The Company believes that non-GAAP net income and non-GAAP earnings per diluted share provide transparent and useful information and are widely used by analysts, investors, and competitors in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
During the first quarter of 2019, the Company updated its calculation methodology to include the use of interest expense net of interest income in the reconciliation of EBITDA and adjusted EBITDA, compared to the historical use of only interest expense, and also to include the non-service component of the Company's pension and postretirement benefit costs in the reconciliation of adjusted EBITDA, non-GAAP net income attributable to
The following tables reconcile the non-GAAP financial measures (unaudited) to their most directly comparable GAAP (unaudited) financial measures (dollars in thousands unless otherwise notes, except per share amounts):
Three Months Ended March 31, |
|||
2019 |
2018 |
||
Operating income |
$ 19,829 |
$ 20,231 |
|
Houghton combination-related expenses |
4,483 |
5,209 |
|
Non-GAAP operating income |
$ 24,312 |
$ 25,440 |
|
Non-GAAP operating margin (%) |
11.5% |
12.0% |
|
Three Months Ended March 31, |
|||
2019 |
2018 |
||
Net income attributable to Quaker Chemical Corporation |
$ 13,844 |
$ 12,732 |
|
Depreciation and amortization |
4,859 |
5,047 |
|
Interest expense, net |
776 |
1,203 |
|
Taxes on income before equity in net income (loss) of associated companies |
4,929 |
5,556 |
|
EBITDA |
$ 24,408 |
$ 24,538 |
|
Equity (income) loss in a captive insurance company |
(346) |
372 |
|
Houghton combination-related expenses |
4,483 |
5,209 |
|
Pension and postretirement benefit costs, non-service components |
896 |
576 |
|
Currency conversion impacts of hyper-inflationary economies |
194 |
218 |
|
Adjusted EBITDA |
$ 29,635 |
$ 30,913 |
|
Adjusted EBITDA margin (%) |
14.0% |
14.6% |
|
Adjusted EBITDA |
$ 29,635 |
$ 30,913 |
|
Less: Depreciation and amortization |
4,859 |
5,047 |
|
Less: Interest expense, net - adjusted (a) |
(86) |
339 |
|
Less: Taxes on income before equity in net income (loss) of associated |
|||
companies - adjusted (b) |
6,040 |
6,659 |
|
Non-GAAP net income |
$ 18,822 |
$ 18,868 |
|
Three Months Ended March 31, |
|||
2019 |
2018 |
||
GAAP earnings per diluted share attributable to Quaker Chemical Corporation |
$ 1.03 |
$ 0.95 |
|
Equity (income) loss in a captive insurance company per diluted share |
(0.03) |
0.03 |
|
Houghton combination-related expenses per diluted share |
0.35 |
0.38 |
|
Pension and postretirement benefit costs, non-service components |
0.05 |
0.03 |
|
Currency conversion impacts of hyper-inflationary economies per diluted share |
0.01 |
0.02 |
|
Non-GAAP earnings per diluted share |
$ 1.41 |
$ 1.41 |
(a) |
Interest expense, net – adjusted excludes $0.9 million of interest costs the Company incurred to maintain the bank commitment related to the pending combination during both the three months ended March 31, 2019 and 2018. |
(b) |
Taxes on income before equity in net income (loss) of associated companies – adjusted includes the Company's tax expense adjusted for the impact of any current and deferred income tax expense (benefit), as applicable, of the reconciling items presented in the reconciliation of net income attributable to Quaker Chemical Corporation to adjusted EBITDA, above, determined utilizing the applicable rates in the taxing jurisdictions in which these adjustments occurred, subject to deductibility. |
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that demand for the Company's products and services is largely derived from the demand for its customers' products, which subjects the Company to uncertainties related to downturns in a customer's business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, significant changes in applicable tax rates and regulations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us, including those related to the previously announced pending Houghton combination and the risk that the transaction may not receive regulatory approval or that regulatory approval may include conditions or other terms not acceptable to us. For more information regarding these risks and uncertainties as well as certain additional risks that we face, you should refer to the Risk Factors detailed in Item 1A of our Form 10-K for the year ended
Conference Call
As previously announced,
About Quaker
Quaker Chemical Corporation |
|||
Condensed Consolidated Statements of Income |
|||
(Dollars in thousands, except share and per share data) |
|||
(Unaudited) |
|||
Three Months Ended March 31, |
|||
2019 |
2018 |
||
Net sales |
$ 211,210 |
$ 212,055 |
|
Cost of goods sold |
135,443 |
136,608 |
|
Gross profit |
75,767 |
75,447 |
|
% |
35.9% |
35.6% |
|
Selling, general and administrative expenses |
51,455 |
50,007 |
|
Combination-related expenses |
4,483 |
5,209 |
|
Operating income |
19,829 |
20,231 |
|
% |
9.4% |
9.5% |
|
Other expense, net |
(635) |
(369) |
|
Interest expense |
(1,214) |
(1,692) |
|
Interest income |
438 |
489 |
|
Income before taxes and equity in net income (loss) of associated companies |
18,418 |
18,659 |
|
Taxes on income before equity in net income (loss) of associated companies |
4,929 |
5,556 |
|
Income before equity in net income (loss) of associated companies |
13,489 |
13,103 |
|
Equity in net income (loss) of associated companies |
411 |
(316) |
|
Net income |
13,900 |
12,787 |
|
Less: Net income attributable to noncontrolling interest |
56 |
55 |
|
Net income attributable to Quaker Chemical Corporation |
$ 13,844 |
$ 12,732 |
|
% |
6.6% |
6.0% |
|
Share and per share data: |
|||
Basic weighted average common shares outstanding |
13,291,589 |
13,245,026 |
|
Diluted weighted average common shares outstanding |
13,338,490 |
13,278,606 |
|
Net income attributable to Quaker Chemical Corporation Common |
$ 1.04 |
$ 0.96 |
|
Net income attributable to Quaker Chemical Corporation Common |
$ 1.03 |
$ 0.95 |
Quaker Chemical Corporation |
|||
Condensed Consolidated Balance Sheets |
|||
(Dollars in thousands, except par value and share amounts) |
|||
(Unaudited) |
|||
March 31, |
December 31, |
||
2019 |
2018 |
||
ASSETS |
|||
Current assets |
|||
Cash and cash equivalents |
$ 71,960 |
$ 104,147 |
|
Accounts receivable, net |
208,003 |
202,139 |
|
Inventories, net |
92,947 |
94,090 |
|
Prepaid expenses and other current assets |
18,403 |
18,134 |
|
Total current assets |
391,313 |
418,510 |
|
Property, plant and equipment, net |
82,316 |
83,923 |
|
Right of use lease assets |
26,069 |
- |
|
Goodwill |
83,204 |
83,333 |
|
Other intangible assets, net |
61,421 |
63,582 |
|
Investments in associated companies |
22,726 |
21,316 |
|
Non-current deferred tax assets |
9,333 |
6,946 |
|
Other assets |
32,141 |
32,055 |
|
Total assets |
$ 708,523 |
$ 709,665 |
|
LIABILITIES AND EQUITY |
|||
Current liabilities |
|||
Short-term borrowings and current portion of long-term debt |
$ 661 |
$ 670 |
|
Accounts and other payables |
91,145 |
92,754 |
|
Accrued compensation |
15,959 |
25,727 |
|
Other current liabilities |
39,743 |
32,319 |
|
Total current liabilities |
147,508 |
151,470 |
|
Long-term debt |
11,720 |
35,934 |
|
Long-term lease liabilities |
20,231 |
- |
|
Non-current deferred tax liabilities |
9,194 |
10,003 |
|
Other non-current liabilities |
73,507 |
75,889 |
|
Total liabilities |
262,160 |
273,296 |
|
Equity |
|||
Common stock, $1 par value; authorized 30,000,000 shares; issued and |
13,334 |
13,338 |
|
Capital in excess of par value |
96,832 |
97,304 |
|
Retained earnings |
413,992 |
405,125 |
|
Accumulated other comprehensive loss |
(79,167) |
(80,715) |
|
Total Quaker shareholders' equity |
444,991 |
435,052 |
|
Noncontrolling interest |
1,372 |
1,317 |
|
Total equity |
446,363 |
436,369 |
|
Total liabilities and equity |
$ 708,523 |
$ 709,665 |
Quaker Chemical Corporation |
|||
Condensed Consolidated Statements of Cash Flows |
|||
(Dollars in thousands) |
|||
(Unaudited) |
|||
Three Months Ended March 31, |
|||
2019 |
2018 |
||
Cash flows from operating activities |
|||
Net income |
$ 13,900 |
$ 12,787 |
|
Adjustments to reconcile net income to net cash provided by operating |
|||
Depreciation |
3,047 |
3,194 |
|
Amortization |
1,812 |
1,853 |
|
Equity in undistributed earnings of associated companies, net of dividends |
(186) |
511 |
|
Deferred compensation, deferred taxes and other, net |
(6,842) |
428 |
|
Share-based compensation |
1,012 |
1,083 |
|
Gain on disposal of property, plant, equipment and other assets |
(9) |
(52) |
|
Insurance settlement realized |
(190) |
(85) |
|
Combination-related expenses, net of payments |
(1,012) |
2,161 |
|
Pension and other postretirement benefits |
(1,346) |
(2,632) |
|
(Decrease) increase in cash from changes in current assets and current |
|||
Accounts receivable |
(5,470) |
(5,827) |
|
Inventories |
946 |
(7,758) |
|
Prepaid expenses and other current assets |
366 |
(1,055) |
|
Accounts payable and accrued liabilities |
(6,008) |
(1,862) |
|
Net cash provided by operating activities |
20 |
2,746 |
|
Cash flows from investing activities |
|||
Investments in property, plant and equipment |
(2,537) |
(3,449) |
|
Payments related to acquisitions, net of cash acquired |
(500) |
(500) |
|
Proceeds from disposition of assets |
8 |
29 |
|
Insurance settlement interest earned |
65 |
19 |
|
Net cash used in investing activities |
(2,964) |
(3,901) |
|
Cash flows from financing activities |
|||
Proceeds from long-term debt |
- |
8,166 |
|
Repayments of long-term debt |
(23,948) |
(197) |
|
Dividends paid |
(4,935) |
(4,724) |
|
Stock options exercised, other |
(1,489) |
(866) |
|
Distributions to noncontrolling affiliate shareholders |
- |
(834) |
|
Net cash (used in) provided by financing activities |
(30,372) |
1,545 |
|
Effect of foreign exchange rate changes on cash |
1,004 |
2,246 |
|
Net (decrease) increase in cash, cash equivalents and restricted cash |
(32,312) |
2,636 |
|
Cash, cash equivalents and restricted cash at the beginning of the period |
124,425 |
111,050 |
|
Cash, cash equivalents and restricted cash at the end of the period |
$ 92,113 |
$ 113,686 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/quaker-chemical-announces-first-quarter-2019-results-300843083.html
SOURCE
Mary Dean Hall, Vice President, Chief Financial Officer and Treasurer, investor@quakerchem.com, T. 1.610.832.4000